Related Experiment Video
Updated: May 3, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Oligocentric Castleman disease: clinical characteristics and surgical outcomes from a single-centre retrospective
Yukai Duan1, Xiang Gao1, Siyu Qian1
1Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Insights
Oligocentric Castleman Disease (OCD) patients show poorer survival than Unicentric CD. Surgery helps symptoms, but asymptomatic cases may benefit from active surveillance, while high-inflammatory types require tailored therapies.
Area of Science:
- Hematology
- Oncology
- Rare Diseases
Background:
- Oligocentric Castleman Disease (OCD) is an under-characterized subtype of Castleman Disease (CD).
- OCD presents intermediate characteristics between Unicentric CD (UCD) and idiopathic Multicentric CD (iMCD).
Purpose of the Study:
- To retrospectively analyze the clinical features, treatment outcomes, and prognosis of 100 CD patients, focusing on OCD.
- To identify predictors of progression-free survival (PFS) in OCD patients.
Main Methods:
- Retrospective analysis of 100 CD patients (63 UCD, 37 OCD).
- Comparison of clinical characteristics, histology, inflammatory markers, and survival between UCD and OCD cohorts.
- Subgroup analysis of OCD patients into asymptomatic and high-inflammatory groups.
Main Results:
- OCD patients exhibited higher rates of mixed-type histology, elevated CRP/ESR, and significantly poorer PFS compared to UCD.
- In the OCD cohort, debulking surgery or chemotherapy yielded an 80% complete response rate.
- Plasmacytic type, non-contiguous lesions, extensive regional involvement, and high inflammatory markers predicted inferior PFS in OCD.
Conclusions:
- Debulking surgery is effective for symptomatic OCD but may not be necessary for asymptomatic patients.
- Hyper-inflammatory states in OCD predict relapse, necessitating careful treatment strategies.
- Active surveillance may be suitable for asymptomatic OCD, while high-risk subgroups require novel therapeutic approaches.
Introduction:
Oligocentric Castleman Disease (OCD), a distinct subtype of Castleman Disease (CD) intermediate between Unicentric (UCD) and idiopathic Multicentric (iMCD) forms, remains poorly characterised.
Methods:
This study retrospectively analysed the clinical characteristics, treatment, and prognosis of 100 CD patients (63 UCD, 37 OligoCD).
Results:
Compared with UCD, OCD patients had a higher proportion of mixed type (Mixed-CD) histology and elevated CRP/ESR levels, along with significantly poorer Progression-Free Survival (PFS) (P = 0.0067). Within the OCD cohort, debulking surgery alone or combined chemotherapy achieved an 80.0% Complete Response (CR) rate; plasmacytic type(PC-CD), non-contiguous lesions, involvement of ≥3 regions, failure to achieve CR after initial treatment, and elevated baseline inflammatory markers were significant predictors of inferior PFS. Exploratory subgroup analysis divided the OCD cohort into asymptomatic and high-inflammatory groups with significantly different PFS (P = 0.042). The rate of progression to iMCD among surgically managed asymptomatic OCD patients in our study was similar to that in a large aMCD cohort predominantly managed with 'watch-and-wait', suggesting 'active surveillance' might be a more appropriate initial strategy for asymptomatic OCD. For the high-inflammatory subgroup, characterised by higher PC-CD rates and more widespread disease distribution despite effective symptom control with surgery, the post-operative relapse risk was higher.
Discussion:
In conclusion, debulking surgery is effective for alleviating symptoms in OCD but may be unnecessary for asymptomatic patients; factors associated with a hyper-inflammatory state predict relapse, underscoring the need for careful treatment planning and exploration of novel therapeutic strategies for this high-risk subgroup.
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Pericarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy

